LONDON and BOSTON, January 9, 2014 /PRNewswire/ --
Increases Focus on Clinical Development of Novel GPCR-targeted Drug Candidates
Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces the appointment of Dr Tim Tasker as Chief Medical Officer (CMO) and Vice President of Development. Dr Tasker will lead the Company's clinical development activities as it advances its rich pipeline of novel GPCR-targeted agents in multiple therapeutic areas.
Help employers find you! Check out all the jobs and post your resume.
